Bromazepam
- Generic Name
- Bromazepam
- Drug Type
- Small Molecule
- Chemical Formula
- C14H10BrN3O
- CAS Number
- 1812-30-2
- Unique Ingredient Identifier
- X015L14V0O
Overview
One of the benzodiazepines that is used in the treatment of anxiety disorders. It is a Schedule IV drug in the U.S. and Canada and under the Convention on Psychotropic Substances. It is a intermediate-acting benzodiazepine.
Background
One of the benzodiazepines that is used in the treatment of anxiety disorders. It is a Schedule IV drug in the U.S. and Canada and under the Convention on Psychotropic Substances. It is a intermediate-acting benzodiazepine.
Indication
For the short-term treatment of insomnia, short-term treatment of anxiety or panic attacks, if a benzodiazepine is required, and the alleviation of the symptoms of alcohol- and opiate-withdrawal.
Associated Conditions
- Anxiety Acute
- Severe Anxiety
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
LEXOTAN TABLET 1.5 mg
Manufacturer:Delpharm Milano, S.r.l
Form:TABLET
Strength:1.5 mg
Online:Yes
Approved: 1988/04/27
Approval:SIN00385P
LEXOTAN TABLET 3 mg
Manufacturer:Delpharm Milano, S.r.l
Form:TABLET
Strength:3 mg
Online:Yes
Approved: 1988/04/27
Approval:SIN00382P
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath